BioSpace News Archive

Genetown

Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVB

Agenus announced that it will hold a conference call to provide detail and to answer any questions regarding its minority cash holdings at Silicon Valley Bank at 8:30 a.m. ET on Monday, March 13th.

March 11, 2023
·
1 min read
Biotech Bay

Veracyte Provides Statement on Impact of Events Surrounding Silicon Valley Bank

Veracyte, Inc. outlined the company’s cash, cash equivalents and short-term investment status in light of the events surrounding Silicon Valley Bank.

March 11, 2023
·
2 min read
Biotech Beach

Ventyx Biosciences Provides Update on Silicon Valley Bank Financial Exposure

Ventyx Biosciences, Inc., has learned that Silicon Valley Bank has been closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation as receiver.

March 11, 2023
·
2 min read
BioCapital

Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB

Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it has no banking relationship with Silicon Valley Bank and no funds on deposit at SVB.

March 11, 2023
·
3 min read
Biotech Bay

Nektar Therapeutics Issues Statement Confirming That It Does Not Hold Any Cash Deposits or Securities at Silicon Valley Bank

Nektar Therapeutics issued a statement confirming that it does not have any accounts at Silicon Valley Bank, and it does not hold any cash deposits or securities at Silicon Valley Bank.

March 11, 2023
·
1 min read
Business

Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing

Cytovance Biologics, Inc. and Phenotypeca Limited have entered into an agreement to provide optimized Saccharomyces cerevisiae strains for biopharmaceutical manufacturing.

March 11, 2023
·
3 min read